MF
SRPT icon

Magnetar Financial’s Sarepta Therapeutics SRPT Stock Holding History

Magnetar Financial’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$297K Buy
+16,551
New +$313K ﹤0.01% 788
2025
Q2 		– Sell
-29,631
Closed -$1.89M – 1126
2025
Q1 		$1.89M Buy
29,631
+29,593
+77,876% +$3.12M 0.02% 280
2024
Q4 		$4.62K Buy
+38
New +$4.66K ﹤0.01% 587
2021
Q2 		– Sell
-6,679
Closed -$498K – 1369
2021
Q1 		$498K Buy
+6,679
New +$616K ﹤0.01% 825
2020
Q4 		– Sell
-5,037
Closed -$707K – 880
2020
Q3 		$707K Buy
+5,037
New +$765K 0.01% 387

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Magnetar Financial's SRPT Position: Q2 2026 in Review

Magnetar Financial opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 16,551 shares worth $297K. The stake represents ﹤0.01% of the portfolio and ranks #788 among its holdings. This is a return to the name: Magnetar Financial previously reported a position in SRPT as recently as Q1 2025.

Magnetar Financial first reported a position in SRPT in Q3 2020 and has held it in 5 quarters since. The position peaked at $1.89M in Q1 2025. 324 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Magnetar Financial held 16,551 shares of Sarepta Therapeutics worth $297K as of Q2 2026.
  • Sarepta Therapeutics was a new Magnetar Financial position in Q2 2026.
  • Sarepta Therapeutics made up ﹤0.01% of Magnetar Financial's portfolio in Q2 2026, its #788 holding.
  • Magnetar Financial first reported a position in Sarepta Therapeutics in Q3 2020 and has held it in 5 quarters since.
  • Magnetar Financial's Sarepta Therapeutics position peaked at $1.89M in Q1 2025.
  • 324 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.